PetMed Express, Inc.

Historical 13F Holders

Symbol
PETS
CUSIP
716382106
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 716382106 since 12/18/2024, largest first.

Filer % of Class Filed
Silvercape Investments Ltd 13D/A
12.1% 6/29/2026
Event 6/29/2026
Renaissance Technologies LLC 13G/A
5.3% 8/13/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (3)
Hotchkis & Wiley Capital Management LLC 13G/A 4.7% 2/14/2025
Event 12/31/2024
Vanguard Group Inc 13G/A 4.7% 1/31/2025
Event 12/31/2024
Diveroli Investment Group LLC 13D
1.8% 2/11/2026
Event 1/11/2025

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 3 978 $1.35 k
2026 Q2 50 4.63 M $8.92 M
2026 Q1 51 5.97 M $13.7 M
2025 Q4 56 6.96 M $22.2 M
2025 Q3 64 6.99 M $17.6 M
2025 Q2 71 7.50 M $25.0 M
2025 Q1 79 7.87 M $33.0 M
2024 Q4 93 8.98 M $43.3 M
2024 Q3 99 9.52 M $35.0 M
2024 Q2 125 12.5 M $50.8 M
2024 Q1 128 16.6 M $87.8 M
2023 Q4 148 16.2 M $123 M
2023 Q3 160 13.3 M $136 M
2023 Q2 167 15.8 M $218 M
2023 Q1 179 17.4 M $282 M
2022 Q4 176 17.6 M $312 M
2022 Q3 194 16.5 M $322 M
2022 Q2 197 17.8 M $354 M
2022 Q1 204 17.6 M $458 M
2021 Q4 207 17.0 M $430 M
2021 Q3 216 16.7 M $448 M
2021 Q2 226 17.7 M $564 M
2021 Q1 225 16.4 M $576 M
2020 Q4 235 18.8 M $602 M
2020 Q3 220 18.6 M $588 M
2020 Q2 238 18.4 M $655 M
2020 Q1 220 17.7 M $513 M
2019 Q4 208 18.2 M $453 M
2019 Q3 194 18.4 M $353 M
2019 Q2 210 21.2 M $359 M
2019 Q1 219 20.3 M $484 M
2018 Q4 217 21.8 M $506 M
2018 Q3 213 19.9 M $656 M
2018 Q2 216 19.4 M $856 M
2018 Q1 222 20.1 M $841 M
2017 Q4 217 18.9 M $859 M
2017 Q3 198 20.6 M $683 M
2017 Q2 189 16.2 M $659 M
2017 Q1 165 16.0 M $323 M
2016 Q4 159 15.5 M $357 M
2016 Q3 158 15.1 M $306 M
2016 Q2 164 15.6 M $293 M
2016 Q1 163 16.5 M $296 M
2015 Q4 159 16.9 M $290 M
2015 Q3 155 17.6 M $283 M
2015 Q2 150 16.2 M $280 M
2015 Q1 151 14.5 M $239 M
2014 Q4 129 13.8 M $199 M
2014 Q3 133 13.3 M $181 M
2014 Q2 137 13.7 M $185 M
2014 Q1 141 13.9 M $187 M